Table 3.
No. of E. coli per Ward | % of Resistance to the Tested Antibiotic | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
CIP | CHL | NAL | GEN | AMP | TET | DOX | SXT | CTX | MEM | |
Ukonga (30) | 56.7 | 43.3 | 73.3 | 22.4 | 70.0 | 61.2 | 59.7 | 49.3 | 63.3 | 3.0 |
Kipawa (67) | 32.8 | 29.9 | 64.2 | 30.0 | 52.2 | 80.0 | 66.7 | 56.7 | 43.3 | 10.0 |
Gongolamboto (22) | 50.0 | 36.4 | 72.7 | 31.8 | 36.4 | 81.8 | 63.6 | 54.5 | 68.2 | 0.0 |
Buguruni (15) | 33.3 | 20.0 | 46.7 | 40.0 | 40 | 60.0 | 20.0 | 26.7 | 33.3 | 6.7 |
Kinyerezi (53) | 39.6 | 39.6 | 56.6 | 50.9 | 50.9 | 64.2 | 43.4 | 41.5 | 39.6 | 5.7 |
Segerea (47) | 34.0 | 31.9 | 63.8 | 34.0 | 53.2 | 72.3 | 46.8 | 55.3 | 61.7 | 4.3 |
Overall resistance | 39.3 | 34.2 | 63.2 | 34.2 | 52.1 | 68.4 | 52.1 | 48.7 | 50.4 | 4.7 |
p-value | 0.237 | 0.569 | 0.419 | 0.046 | 0.223 | 0.254 | 0.018 | 0.315 | 0.026 | 0.599 |
Key: CIP, ciprofloxacin; CHL, chloramphenicol; NAL, nalidixic acid; GEN, gentamycin; AMP, ampicillin; TET, tetracycline; DOX, doxycycline; SXT, trimethoprim/sulfamethoxazole; CTX, cefotaxime; MEM, meropenem.